Combination of Fluoroscopy and Ultrasonography Guidance in Sacroiliac Joint Injections. A Randomised Controlled Trial
1 other identifier
interventional
38
1 country
1
Brief Summary
The primary purpose of this study is to investigate the effect of the application of sacroiliac joint injection guided by combination of ultrasonography and fluoroscopy on the duration of the procedure and the amount of radiation exposed during the procedure, compared to the application of only fluoroscopy-guided technique. Secondary objectives are to evaluate the effectiveness of the treatment with both methods and to record the adverse events that may be encountered during the procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
March 15, 2023
CompletedFirst Posted
Study publicly available on registry
July 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedMarch 11, 2026
March 1, 2026
11 months
March 15, 2023
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Processing Time
The processing time will be measured by the other researcher in the processing room with the help of a stopwatch. The stopwatch will be started when the needle touches the patient and will be stopped when the procedure is finished. It will be recorded in seconds
during the intervention
Secondary Outcomes (4)
Fluoroscopy Time
during the intervention
Kerma-area Product (μGy)
during the intervention
Visual Analogue Scale
baseline, change from baseline VAS at 1 month after intervention
Oswestry Low Back Pain Disability Questionnaire
baseline, change from baseline VAS at 1 month after intervention
Study Arms (2)
Combined ultrasonography and flouroscopy guided injeciton
EXPERIMENTALIn 19 patients selected after randomization, the procedure will first be started with ultrasound and then continued with fluoroscopy.
Flouroscopy guided injection
ACTIVE COMPARATORIn 19 patients selected after randomization, the procedure will be performed only through fluoroscopy.
Interventions
In the ultrasound+fluoroscopy group, the sacroiliac injection will be started under ultrasound guidance. With the help of ultrasound, when sacral 2 foramen is seen the needle will be advanced to the entrance of the sacroiliac joint under real-time in-plane view. After considering intra-articular placement, fluoroscopy guidance will be initiated. An anteroposterior image will be taken to confirm whether contrast material is within the joint. If intra-articular placement is not achieved after contrast medium infiltration, needle reposition will be performed under fluoroscopy for correct needle placement. After the intraarticular contrast pattern is seen, 1 ml of 40 mg methylprednisolone + 1 ml of 1% lidocaine mixture will be injected.
In the fluoroscopy group, the advancement of the needle into the sacroiliac joint will be performed by taking anteroposterior and lateral views. In the same way, the needle tip will be placed in the inferior of the sacroiliac joint, and contrast material distribution examination and injection of the drug will be performed as in the ultrasound + fluoroscopy group.
Eligibility Criteria
You may qualify if:
- Low back and/or gluteal pain and/or groin pain without radicular extension below the L4 level for more than 3 months
- Pain score greater than 3 according to NRS
- Unresponsiveness to conservative treatment (such as exercise, NSAID)
- At least 3 of the five sacroiliac provocation tests (FABER (Patrick), thigh thrust, Gaenslen, sacroiliac compression, and sacroiliac distraction tests) are positive
You may not qualify if:
- Refusing to participate in the study
- Pregnancy
- Infective sacroiliitis
- Malignancy
- Osteoporosis
- Mechanical lumbosacral pathologies (spondylolisthesis, scoliosis, stenosis, etc.)
- Neurological finding in the lower extremity
- Pain spreading below the knee
- History of spinal surgery
- History of allergy to drugs to be injected (local anesthetic, contrast material, steroid allergy)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Ankara, Cankaya, 06800, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Serdar KESIKBURUN, MD
SBU,Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
March 15, 2023
First Posted
July 13, 2023
Study Start
February 15, 2023
Primary Completion
January 15, 2024
Study Completion
February 15, 2024
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share